A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin.
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
84 readers recommended
45 readers recommended
You call that an artificial pancreas? The pathway to closed loop system.
34 readers recommended
On July 10, the JDRF and 161 delegates for the Children’s Congress traveled to Capitol Hill inWashington, D.C. to call for support of type 1 diabetes research funding...
30 readers recommended
Kelly’s experience in UVA’s overnight closed loop trial makes for fantastic dreams.
56 readers recommended
Are all carbs created equal? Adam learns why 30 grams of carbs is NOT always 30 grams of carbs…
39 readers recommended
On December 2, the influential Helmsley Charitable Trust (HCT), one of the world’s largest funders of type 1 diabetes research – and the 12th largest private foundation...
28 readers recommended
Why Targeting a Cure has been such a deeply personal endeavor for Kelly.
48 readers recommended
Last month, in early September, results from the DPP-4 inhibitor cardiovascular outcomes trials SAVOR-TIMI 53 (for Bristol Myers Squibb and AstraZeneca’s Onglyza) and...
33 readers recommended
On November 18, the University of Virginia (UVA) announced that it received a $3.4 million NIH grant for three artificial pancreas studies to be conducted at UVA and...
34 readers recommended
Where are we on the road to curing type 1 diabetes? Read about our eBook with the American Diabetes Association, with great inspiration from JDRF and the Helmsley...
42 readers recommended
On September 12, Sanofi announced that it withdrew the FDA application for its once-daily GLP-1 agonist lixisenatide (named Lyxumia in Europe) for type 2 diabetes. It is...
35 readers recommended
Dr. Damiano reveals the much anticipated data from the bionic pancreas trials at the biggest diabetes tech conference of the year.
49 readers recommended
Five key insights from April’s big-deal artificial pancreas meeting in Washington, DC.
JDRF and PureTech Launch Groundbreaking New Fund, T1D Innovations, Designed to Fund Type 1 Therapies
24 readers recommended
On Tuesday October 15, JDRF and PureTech announced the launch of T1D Innovations, an exciting new fund that aims to supply crucial funding for the development of type 1...
41 readers recommended
How you can help to prevent type 1 diabetes…
27 readers recommended
The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.
51 readers recommended
Can more type 2 therapies be used for type 1 diabetes?
26 readers recommended
Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball.
61 readers recommended
Kelly’s transformative experience wearing an artificial pancreas for five days.
35 readers recommended
On November 1, Dr. Ed Damiano presented results from the Beacon Hill study and Summer Camp study of the bionic pancreas at Carb DM ’s Second Anniversary. For more...